Radiopaque balloon catheter and guidewire to facilitate alignment

ABSTRACT

An apparatus includes a catheter having a balloon including at least one first radiopaque marking. A guidewire guides the balloon to the treatment area, and includes at least one second radiopaque marking adapted for corresponding to the at least one first radiopaque marking of the balloon when positioned at the treatment area. Related aspects and methods are disclosed.

This application claims the benefit of U.S. Provisional PatentApplication Ser. No. 61/747,422, which is incorporated herein byreference.

TECHNICAL FIELD

This disclosure relates generally to interventional medical procedures,such as angioplasty, and, more particularly, to a radiopaque ballooncatheter and a corresponding guidewire with radiopaque markings tofacilitate co-location of the two structures at a treatment area.

BACKGROUND OF THE INVENTION

Catheters including balloons are routinely used to resolve or addressflow restrictions or perhaps even complete blockages in tubular areas ofa body, such as arteries or veins. In many clinical situations, therestrictions are caused by hard solids, such as calcified plaque, andmay sometimes involve the use of high pressures to compact suchblockages. Commercially available balloons employ complex technology toachieve high pressure requirements without sacrificing the profile ofthe balloon. Besides high pressure requirements, the balloons shouldalso be resistant to puncture, easy to track and push, and present a lowprofile, especially when used for angioplasty.

The clinician performing the angioplasty procedure should be able tolocate the position of the uninflated balloon with accuracy, so that theballoon will be properly positioned once inflated. This isconventionally accomplished by attaching marker bands on the cathetershaft corresponding to the ends of the balloon working surface. This“working surface” is the surface along the portion of the balloon thatis used to achieve the desired treatment effect, such as contacting thecalcified plaque (which surface in the case of a balloon having conicalor tapering sections at the proximal and distal ends is typicallyco-extensive with a generally cylindrical barrel section).

However, misalignment of the marker bands during placement along theshaft sometimes results in their failure to correspond precisely to theextent of the working surface. This misalignment may prevent theclinician from accurately identifying the location of the workingsurface of the balloon during an interventional procedure. Also, whensuccessive intravascular interventions are made, such as during apre-dilatation using a first catheter followed by dilatation using asecond catheter, the clinician must guess at the location where thepre-dilatation occurred. In either case, this uncertainty may lead to ageographic misalignment, or “miss,” of the desired contact between theintended treatment area and the working surface of the balloon. It isespecially desirable to avoid such an outcome when the balloon isdesigned to deliver a payload (such as a therapeutic agent (e.g., adrug, such as paclitaxel, rapamycin, heparin and the like), a stent, astent graft, or a combination thereof) or a working element (such as acutter, focused force wire, or the like) to a specified location withinthe vasculature, since a miss may, at a minimum, prolong the procedure(such as, for example, by requiring redeployment of the balloon or theuse of another balloon catheter in the case of a drug coated balloon),and possibly result in an inferior outcome if the lesion is not properlytreated as a result of the misalignment.

In order to assess the length of a lesion from a location external tothe body, a clinician may use an external ruler, which in one form iscalled a “LeMaitre” tape. While the use of such a ruler or tape mayallow for a more precise assessment of the lesion length and an areatreated by a pre-dilitation step, it is not without limitations. Forone, a displacement or difference in the apparent position of the lesionmargins results when viewed along two different lines of sight. This“parallax” can lead to an inaccurate measurement and, at a minimum,contribute to the geographic misalignment of the working surfacerelative to the lesion. The use of such a ruler may also lead toinferior measurements when the vasculature at issue is particularlytortuous.

Accordingly, a need exists for a manner in which to position a ballooncatheter into the vasculature at a treatment area with enhancedaccuracy, and also in a manner that is highly repeatable.

SUMMARY OF THE INVENTION

An object of the disclosure is to provide a radiopaque balloon catheterthat may align with radiopaque markings on an associated guidewire inorder to ensure co-location of the two structures at a treatment area.

One aspect of the disclosure relates to a catheter having a balloonincluding at least one first radiopaque marking. A guidewire is providedfor guiding the balloon to a treatment area. The guidewire includes atleast one second radiopaque marking adapted for corresponding to the atleast one first radiopaque marking of the balloon when positioned at thetreatment area.

In one embodiment, the balloon comprises two first radiopaque markingsdefining the location of a working surface, and the guidewire includesat least two second radiopaque markings arranged to align with the firstradiopaque markings of the balloon. The balloon may comprise two firstradiopaque markings defining the location and a length of the balloon,and the guidewire may include at least two second radiopaque markingsarranged to align with the first radiopaque markings of the balloon. Theballoon may comprise two additional first radiopaque markings definingthe location of a length of the balloon.

The at least two radiopaque markings of the guidewire may comprise apair of equidistantly spaced markings. A plurality of pairs ofradiopaque markings may be provided on the guidewire, each paircorresponding to a pair of radiopaque markings on the balloon. The pairsof radiopaque markings on the guidewire may be equidistantly spaced, ormay be irregularly spaced.

A centered radiopaque marking may be provided on the guidewire. Thiscentered marking when present may be equidistant from at least two firstradiopaque markings on the guidewire corresponding to the ends of thetreatment area.

In any embodiment, the balloon may include a treatment selected from thegroup consisting of a drug, a stent, a stent graft, a cutter, a focusedforce wire, or any combination thereof.

In accordance with another aspect of the disclosure, an assemblyincluding a plurality of balloons is provided. Each of the balloonsincludes at least two first radiopaque markings. A guidewire is alsoprovided with at least two second radiopaque markings corresponding tothe at least two first radiopaque markings on each of the plurality ofballoons.

In one embodiment, the at least two first radiopaque markings on eachballoon correspond to the location of a working surface. The at leasttwo second radiopaque markings on the guidewire may correspond to theends of a treatment area. The plurality of balloons may each havedifferent lengths, and the balloon or balloons include a treatmentselected from the group consisting of a drug, a stent, a stent graft, acutter, a focused force wire, or any combination thereof.

Still a further aspect of the disclosure pertains to an apparatus fortreating a treatment area in the vasculature using a catheter having aballoon with one or more first radiopaque markings. The apparatuscomprises a guidewire for guiding the balloon to the treatment area. Theguidewire includes at least one pair of second radiopaque markingscorresponding to the one or more first radiopaque markings on theballoon.

In one embodiment, the second radiopaque markings on the guidewire areequidistantly spaced. In another embodiment, the second radiopaquemarkings are irregularly spaced. Also included may be a centeredradiopaque marking on the guidewire, equidistant from at least two ofthe second radiopaque markings.

In any embodiment of the guidewire, a balloon catheter may also beprovided. This balloon catheter may also include a treatment fortreating the treatment area. The treatment may be selected from thegroup consisting of a drug, a stent, a stent graft, a cutter, a focusedforce wire, or any combination of the foregoing.

Also disclosed is a method of assembling an assembly including acatheter including a balloon having at least one radiopaque marking. Themethod comprises providing a guidewire for guiding the catheter, saidguidewire including at least one second radiopaque marking adapted forcorresponding to the at least one first radiopaque marking of theballoon.

BRIEF DESCRIPTION OF THE FIGURES

FIGS. 1-4 show a catheter according to an embodiment of the disclosure.

FIGS. 5-13 show details of a catheter according to different embodimentsof the disclosure.

FIGS. 14-16 show details of a guidewire used in different embodiments ofthe disclosure.

FIG. 17 shows a way of using a catheter according to an embodiment ofthe disclosure during angioplasty.

FIGS. 18-23 show details of different catheters according to embodimentsof the disclosure.

MODES FOR CARRYING OUT THE INVENTION

The description provided below and in regard to the figures applies toall embodiments unless noted otherwise, and features common to eachembodiment are similarly shown and numbered.

Provided is a catheter 10 having a distal portion 11 with a balloon 12mounted on a catheter tube 14. Referring to FIGS. 1, 2, and 3, theballoon 12 has an intermediate section 16, or “barrel” having theworking surface W, and end sections 18, 20. In one embodiment, the endsections 18, 20 reduce in diameter to join the intermediate section 16to the catheter tube 14 (and thus sections 18, 20 are generally termedcones or cone sections). The balloon 12 is sealed to catheter tube 14 atballoon ends (proximal 15 a and distal 15 b) on the end sections 18, 20to allow the inflation of the balloon 12 via one or more inflationlumens 17 extending within catheter tube 14 and communicating with theinterior of the balloon 12.

The catheter tube 14 also includes an elongated, tubular shaft 24forming a guidewire lumen 23 that directs the guidewire 26 through thecatheter 10. As illustrated in FIG. 3, this guidewire 26 may be insertedthrough a first port 25 of a connector, such as a hub 27, into the lumen23 to achieve an “over the wire” (OTW) arrangement, but could also beprovided in a “rapid exchange” configuration in which the guidewire 26enters the lumen through a lateral opening 14 a closer to the distal end(see FIG. 4). A second port 29 may also be associated with catheter 10,such as by way of connector 27, for introducing a fluid (e.g., saline, acontrast agent, or both) into the interior of the balloon 12 via theinflation lumen 17.

Balloon 12 may include a single or multi-layered balloon wall 28. Theballoon 12 may be a non-compliant balloon having a balloon wall 28 thatmaintains its size and shape in one or more directions when the balloonis inflated. The balloon 12 in such case also has a pre-determinedsurface area that remains constant during and after inflation, also hasa pre-determined length and pre-determined circumference that each, ortogether, remain constant during and after inflation. However, theballoon 12 could be semi-compliant or compliant instead, depending onthe particular use.

In order to provide for enhanced locatability during an interventionalprocedure, the balloon 12 may have a radiopaque quality. In oneembodiment, this radiopaque quality is provided in a manner that allowsfor a clinician to differentiate, with relative ease and high precision,one portion of the balloon 12 from another (such as the barrel section16 including the working surface W from the cone sections 18, 20). Thishelps the clinician ensure the accurate positioning of the balloon 12and, in particular, the working surface W, at a specified treatmentarea. This may be especially important in the delivery of a particularitem, such as a drug or stent, via the balloon working surface W, asoutlined in more detail in the following description.

In one embodiment, the radiopaque quality is achieved by providing orstrategically positioning one or more at least partially radiopaqueidentifiers or markings 30. These markings 30 are provided at one ormore locations on the balloon wall 28 (either on it or within it) tocreate a defined portion as the working surface W. As shown in FIGS.5-7, this marking 30 may be provided in the form of a pair of markings30, including a first strip 32 a located at the proximal end of theworking surface W, and a second strip 32 b provided at the distal end ofthe working surface W (and either on the barrel section 16, as shown inFIG. 5, or on the cone sections 18,20, as shown in FIG. 6). In otherwords, the first and second strips 32 a, 32 b, have their outer edgesproximally or distally, as the case may be, in alignment with the pointat which the barrel section 16 transitions to form the cone sections 18,20, including in the deflated state of the balloon 12.

The strips 32 a, 32 b may be provided in the form of narrow, elongatedbands that extend around the entire circumference of the balloon 12 atthe desired location(s) (including possibly at a medial portion of theworking surface W, which helps the clinician to confirm the fullinflation of the balloon 12). In any case, the marking 30 may optionallybe provided in a manner that does not require making the entire workingsurface W radiopaque, and also in a manner that does not prevent theworking surface W from making full contact with the treatment area inthe intended fashion (i.e., the marking 30 does not appreciably increasethe diameter of the balloon 12, including when inflated). Likewise, themarking 30 provided in this manner is separate and spaced apart from anyinner member within the interior compartment of the balloon 12, such asthe shaft 24 forming the guidewire lumen 23.

The balloon 12 with markings 30 in this embodiment may be created invarious ways. For example, the markings 30 may be provided by applying aradiopaque material to a surface of the balloon wall 28 at the desiredlocation in the form of a coating. This may be done by inking, spraying,printing, stamping, painting, adhering, or otherwise depositing (such asby chemical vapor deposition) the radiopaque material onto the balloonwall 28 (possibly with the application of a mask or the like, in whichcase the techniques of dipping or rolling the balloon 12 in theradiopaque material to form the desired coating could be used). Themarking 30 may be provided during the process for fabricating theballoon wall 28, such as for example during a coextrusion or blowmolding process.

In this or other embodiments, the marking 30 is provided along a portionof the balloon 12 other than along the working surface W, which surfacemay include no radiopaque identifier or marking of any kind. Forexample, as shown in FIG. 6, the marking 30 may be provided only on oneor both of the cone sections 18, 20 of the balloon 12. In oneembodiment, as illustrated, the marking 30 is provided along the conesections 18, 20 up to the location in the longitudinal or axialdirection where the working surface W begins and ends (e.g., the pointswhere the cone sections 18, 20 transition to the barrel section 16 atthe proximal and distal ends, which are considered boundaries or edgesof the working surface).

In this or other embodiments, the marking 30 may extend along a portionof the cone sections 18, 20, or as shown in FIG. 7, may extend along theentire cone section 18, 20, or at least to the point where it attachesto the catheter tube 14 (and thus may provide an indication of theoverall balloon length L). In either case, no portion of the catheter 10associated with the working surface W (including the underlying shaft24), may include an added radiopaque marker, element or material.Consequently, under fluoroscopy, the entire working surface W may beclearly differentiated from the portion of the balloon 12 including theradiopaque marking 30 or markings, and may also be differentiated formthe full balloon length L.

In FIG. 8, it is shown that a radiopaque quality may be provided so asto create an accurate indication of the overall balloon length L (thatis, the distance between the ends 15 a, 15 b) in order to make theballoon 12 locatable without regard to any marker or the like on theshaft 24 forming the guidewire lumen 23. This may be accomplished byproviding the radiopaque identifier in the form of a marking 30 at oradjacent each of the locations where the balloon 12 terminates, such asfor example at the proximal and distal ends 15 a, 15 b or on the bondsat the tube 14 or tip P. This marking 30 may comprise a strip in theform of circumferential or annular bands 34 a, 34 b, similar to strips32 a, 32 b described above in another embodiment, and may be applied inthe same or a different manner. As shown in FIG. 9, the strips 32 a, 32b (whether on the cone sections 18, 20 or barrel section 16) and bands,34 a, 34 b may also be used together to allow for the clear and preciseidentification of both the ends of the balloon 12 and the workingsurface W, as well as the overall balloon length L (see FIG. 13).

The balloon 12 may also be provided with radiopaque markings that differbetween the cone sections 18, 20 and the barrel section 16. Thus, asshown in FIG. 10, the barrel section 16 may include a plurality ofmarkings 30 comprising, for example, a first pattern (e.g., diagonalstrips 37). Additionally or alternatively, one or both of the conesections 18, 20 may include a second pattern, which may be differentfrom the first pattern (e.g., circles 39), thus providing an indicationof the working surface W. As should be appreciated, it is also possibleto provide only one or both of the cone sections 18, 20 with theselected pattern, such that the barrel section 16 (and thus the workingsurface W) remains substantially non-radiopaque, or in any eventincludes no added radiopacifier.

Likewise, one or more of the markings 30 may take other forms ofindicia, such as a logo O or alphanumeric information (such as a brand,trademark information, model or item number, catalog number, rated burstpressure, balloon length, balloon diameter, or the like), which againmay be provided on the barrel section 16, cone sections 18, 20, or anycombination. This identifier may be provided in a manner such that itcan be perceived in the deflated state, or such that it may be read andunderstood when the balloon 12 is inflated or expanded, or both. Inaddition to helping define the location of the working surface W, thismay also allow the clinician to verify or confirm that the correctballoon has been used and that it was successfully deployed or inflated.Still another possibility is to provide graduated radiopaque markings,such as a rule, gradations, or a scale, that indicate the relativedimensions of the balloon 12 on inflation, which may be checkedexternally for confirmation, if necessary or desired (such as by using aLeMaitre tape, a version of which is distributed under the VASCUTAPEbrand).

Turning to FIGS. 11 and 12, it can be understood that the radiopaqueidentifier may be in the form of one or more radiopaque markings 30extending longitudinally along only one or both of the cone sections 18,20 of the balloon 12, either along the entire cone section 20, as shown,only partially, or on cone section 18. For example, as shown in FIG. 11,a single narrow strip 38 a may extend longitudinally between the distalend 15 b of the balloon 12 and the distal edge of the working surface W.Alternatively, as shown in FIG. 12, a plurality of such strips,including but not limited to three strips 38 a, 38 b, 38 c, may beprovided. The plural strips may be spaced in the circumferentialdirection, and may have a greater spacing adjacent to the workingsurface W than at the ends 15 a or 15 b of the balloon 12 (at whichpoints, the strips may actually converge and contact each other, or mayremain spaced apart). The use of a plurality of strips, such as two,three 38 a, 38 b, 38 c, or four or more, along one or both of conesections 18, 20 may allow the clinician to be better able to detect theexistence of pancaking, since the strips 38 a, 38 b, 38 c, appear to befarther apart when the balloon 12 is inflated or pancaked, and closerwhen the balloon 12 is properly deflated (12′) and not flattened(compare FIGS. 12 and 13).

Balloons 12 that carry one or more surface elements, such as a payload(drug, stent, or both) or a working implement (cutter, focused forcewire, or the like) into the vasculature may also benefit from theforegoing description of marking techniques. For example, as shown inFIG. 5, a balloon 12 including a defined working surface W, such as byproviding radiopaque markings 30 at the transitions between the barrelsection 16 and cone sections 18, 20, may include a portion coated withsuch a drug D, such as one designed for achieving a desired therapeuticeffect when applied to the interior of the vessel. The radiopaqueidentifier, such as marking 30, may also correspond to the location ofthe drug D on the balloon 12, such as along the entire working surface Wor only a portion of it.

The identifier may be provided by mixing a radiopaque agent or materialin the drug formulation (e.g., in the drug or therapeutic agent coating)such that all portions of the balloon 12 coated with the drug becomevisible under fluoroscopy, by coating a portion of the balloon with aradiopaque material to which the drug formulation preferentially adheres(such that uncoated areas are not covered by the drug), or by adheringthe drug formulation to portions of the balloon surface (such as theworking surface W) that are not treated with radiopaque material (suchas the cone sections in FIG. 7). Alternatively or additionally, anidentifier providing the desired radiopacity may be embedded in the wall28, including for example by providing it as a material layer of thewall 28, or in a single layer between multiple layers of the wall 28.The drug D may be applied to the inflated balloon as part of themanufacturing process, and prior to folding for insertion in thevasculature. The clinician may thus with the benefit of a fluoroscopedetermine the precise positioning of the working surface W prior toinflating the balloon 12 in the vasculature to deliver the drug D to thedesired location and provide the desired treatment regimen.

Examples of radiopaque materials include, but are not limited to, finelydivided tungsten, tantalum, bismuth, bismuth trioxide, bismuthoxychloride, bismuth subcarbonate, other bismuth compounds, bariumsulfate, tin, silver, silver compounds, rare earth oxides, and manyother substances commonly used for X-ray absorption. The amount used mayvary depending on the desired degree of radiopacity.

The marking 30 may also comprise a radiopaque material applied to theinterior surface of the balloon wall 28, such as by painting or otherbonding. In one example, the radiopaque material comprises gold appliedto the exterior or interior surface of the balloon 12, such as in theform of a band (which may be any of the bands described herein). Thegold may be applied in leaf form, given its softness and malleability,which also means that it will not in any way hinder the expansion of theballoon 12.

The guidewire 26 for guiding the balloon 12 to the treatment site mayalso include one or more radiopaque markings 26 a adapted to align withthe radiopaque markings 30. It is clear to the skilled person from FIG.5 that this alignment will typically occur if the working surface of theballoon is positioned at the treatment area. For example, as shown inFIGS. 14 and 15, these markings 26 a may be provided at intervals alongthe length of the guidewire 26 (equidistant and regular, or irregular(such as at increasing frequency or smaller intervals from a givenreference point). As shown in FIG. 16, the markings 26 a may also beprovided in matched pairs, groups, or sets that may be symmetricalrelative to a centered marking 26 b (not necessarily at the center ofthe guidewire 26). In order to further enhance the flexibility of use,the markings 26 a may be provide so as to correspond to the markings 30,such as bands 32 a, 32 b or the like, on various different lengths ofballoons (note dimensions L1, L2, L3, and L4, which may for examplecorrespond to typical balloon lengths (including from shortest tolongest) for a particular procedure, such as 40 cm, 60 cm, 80 cm, and120 cm). The plurality of pairs of radiopaque markings 26 a on theguidewire 26 may each correspond to a pair of radiopaque markings on asingle balloon 12 (such as the balloon of FIG. 9).

In practice, at least partially radiopaque guidewire 26 may bepositioned at a treatment area A within a vessel V, as shown in FIG. 17,such as by using a device called an introducer 1. For instance, thepositioning may be such that one or more of the radiopaque markings 26 aalign with the treatment area A in a predetermined manner, oralternatively, the location of the treatment area A relative to themarkings 26 a may be noted. A balloon 12 with radiopaque markings 30,such as bands 32 a 32 b, may then be co-located with the guidewire 26such that the various radiopaque markings 26 a, 30 correspond to eachother, as shown in FIGS. 18-20. As should be appreciated, the FIGS. 18and 19 embodiments include a guidewire 26 with irregular markings 26 aof different lengths (but FIG. 19 includes a clear center marking 26 b),whereas the FIG. 20 embodiment includes regular markings 26 a, but inboth cases alignment with the markings 30 on the balloon 12 may beeasily achieved. Likewise, the markings 30 on the balloon 12 may takethe other forms noted herein, such as by being positioned on the conesections 18, 20 as shown in FIGS. 21-23.

As a result of this approach, improved alignment is assured, which mayhelp to avoid the geographic misalignment between the balloon 12 and thetreatment area A. This is especially true during repositioning of asecond balloon including a treatment, such as during a secondintervention, since the guidewire 26 will remain at the pre-positionedlocation, as will the radiopaque markings 26 a or 26 b. Accordingly, ahigh degree of repeatability is also afforded.

The radiopaque markings 26 a, 26 b of the guidewire 26 may be providedin a variety of ways, but should not compromise the desired flexibilitytypically afforded. They may be formed as integral parts of the wire, ormay be separately attached (including by bonding, winding (e.g., aspring), coating, or like processes). Specific examples include formingthe wire 26 by winding a highly radiopaque winding wire of platinum,gold, or tungsten about a central core wire, applying a radiopaque inkto the wire, bonding a radiopaque sleeve to the wire, such as a tungstenfilled polymer sleeve, or affixing a series of small radiopaque metalbands to the wire. The markings 26 a may be provided as radiopaqueportions of the wire 26 interposed with non-radiopaque portions, or themarkings 26 a may comprise radiopaque portions of the wire 26 that havea different radiopaque quality as compared to other portions of thewire.

While the disclosure presents certain embodiments to illustrate theinventive concepts, numerous modifications, alterations, and changes tothe described embodiments are possible without departing from the sphereand scope of the present invention, as defined in the appended claims.For example, the marking on the balloon 12 could be a one or morelongitudinal strips corresponding in length to the length of the workingsurface W. Any ranges and numerical values provided in the variousembodiments are subject to variation due to tolerances, due tovariations in environmental factors and material quality, and due tomodifications of the structure and shape of the balloon, and thus can beconsidered to be approximate and the term “approximately” means that therelevant value can, at minimum, vary because of such factors. Also, thedrawings, while illustrating the inventive concepts, are not to scale,and should not be limited to any particular sizes or dimensions.Accordingly, it is intended that the present disclosure not be limitedto the described embodiments, but that it has the full scope defined bythe language of the following claims, and equivalents thereof.

The invention claimed is:
 1. An apparatus for treating a treatment areain a vasculature comprising: a catheter having a balloon with a pair offirst radiopaque markings identifying the ends of a cylindrical portionof the balloon, the cylindrical portion located between tapered portionsof the balloon connected to a shaft of the catheter; and a guidewire forguiding the balloon to the treatment area, said guidewire including aplurality of second radiopaque markings, said plurality of secondradiopaque markings including at least one pair of second radiopaquemarkings, the at least one pair of second radiopaque markingscorresponding in location to the pair of first radiopaque markings onthe balloon, such that one of the first markings aligns with one of thesecond markings and another of the first markings aligns with another ofthe second markings.
 2. The apparatus of claim 1, wherein the pluralityof second radiopaque markings on the guidewire comprise at least threesecond radiopaque markings that are equidistantly spaced.
 3. Theapparatus of claim 2, wherein the at least three second radiopaquemarkings comprise a centered radiopaque marking on the guidewire,equidistant from at least two of the second radiopaque markings.
 4. Theapparatus of claim 3, wherein the at least one pair of second radiopaquemarkings comprises a plurality of pairs of second radiopaque markings,and wherein each of the plurality of pairs of second radiopaque markingsis equidistantly spaced on each longitudinal side of the centeredradiopaque marking.
 5. The apparatus of claim 4, wherein the pluralityof second radiopaque markings are irregularly spaced.
 6. The apparatusaccording to claim 1, further including a treatment for treating thetreatment area.
 7. The apparatus of claim 1, wherein the ballooncomprises a drug.
 8. The apparatus of claim 1, wherein the pair of firstradiopaque markings indicate the ends of a working surface of theballoon.
 9. The apparatus of claim 1, wherein the plurality of secondradiopaque markings on the guidewire comprise a third radiopaque markingspaced a first distance from a fourth marking, and a fifth radiopaquemarking spaced a second distance from the third radiopaque marking. 10.The apparatus of claim 9, wherein the first and second distances areequal.
 11. The apparatus of claim 9, wherein the first and seconddistances are unequal.
 12. An apparatus for treating a treatment area ina vasculature comprising: a first catheter having a first balloon with apair of first radiopaque markings identifying a location of a workingsurface of the first balloon; and a guidewire for guiding the balloon tothe treatment area, said guidewire including a plurality of secondradiopaque markings, said plurality of second radiopaque markingsincluding at least one pair of second radiopaque markings correspondingin position to the pair of first radiopaque markings of the firstballoon.
 13. The apparatus of claim 12, wherein the pair of firstradiopaque markings indicate boundaries of the working surface, and theat least one pair of second radiopaque markings match the position ofthe pair of first radiopaque markings.
 14. The apparatus of claim 12,further including a payload on the working surface of the first balloonfor treating the treatment area.
 15. The apparatus of claim 12, furtherincluding: a second catheter having a second balloon with one or morethird radiopaque markings identifying a location of a working surface ofthe second balloon; and wherein: the guidewire includes at least onepair of fourth radiopaque markings corresponding in position to the oneor more third radiopaque markings of the second balloon.
 16. Theapparatus of claim 12, wherein: the pair of first radiopaque markingsare a first pair of first radiopaque markings and the first balloonfurther comprises a second pair of first radiopaque markings; the atleast one pair of second radiopaque markings correspond in position tothe first pair of first radiopaque markings; and the guidewire furtherincludes a pair of third radiopaque markings that correspond in positionto the second pair of first radiopaque markings.
 17. An apparatus fortreating a treatment area in a vasculature comprising: a first catheterhaving a balloon with a first radiopaque marking identifying a firstboundary of a working surface of the balloon and a second radiopaquemarking identifying a second boundary of the working surface of theballoon; and a guidewire for guiding the balloon to the treatment area,said guidewire including a third radiopaque marking for aligning withthe first radiopaque marking and a fourth radiopaque marking foraligning with the second radiopaque marking when the guidewire ispositioned within the balloon.
 18. The apparatus of claim 17, wherein afirst spacing between the first and second radiopaque markings isgreater than a second spacing between the third radiopaque marking tothe fourth radiopaque markings.
 19. The apparatus of claim 17, wherein aspacing between the third and fourth radiopaque markings corresponds toa distance between the first boundary and the second boundary.